Ipamorelin (5mg/10mg)
The Cleanest Growth Hormone Releaser Available
Order Ipamorelin (5mg/10mg) online for laboratory research. Compare the listed vial options and current price, then add your selection to cart and continue to checkout. Review available COA records for the exact product, strength and lot. Research Use Only; not for human or veterinary use.
Ipamorelin is listed for growth hormone laboratory research. Catalog vial contents are 5mg / 10mg; select the required strength before ordering. This material is supplied for Research Use Only, not as a medicine or a product for human or veterinary use.
Research Applications & Benefits
- Most selective GH releaser
- No cortisol/prolactin increase
- Clean, isolated GH release
- Excellent safety profile
What is Ipamorelin?
Triggers GH release with exceptional selectivity — without affecting cortisol, prolactin, or hunger.
Listed vial contents: 5mg / 10mg. These are supplied quantities, not administration doses. Current pricing and availability are shown in the strength selector.
What mechanisms are being studied?
Ipamorelin is a synthetic pentapeptide that selectively activates the growth hormone secretagogue receptor (GHS-R1a). What makes it unique among GHRPs is its exceptional selectivity — it stimulates GH release without measurably affecting cortisol, prolactin, aldosterone, or hunger (ghrelin-like effects). It is considered the 'cleanest' GHRP available.
What are the research questions?
- Selective GH release: Gold standard for GH stimulation without unwanted hormonal side effects.
- Post-surgical recovery: Studied for accelerating recovery, including bone fracture healing and post-operative gut function.
- Body composition: Supports lean mass gain and fat reduction through selective GH elevation.
- Sleep optimization: GH pulses during sleep are amplified without affecting sleep architecture.
What does the published work describe?
Raun K et al. (Eur J Endocrinol 1998) — GH release potency comparable to GHRP-6 but without appetite stimulation or cortisol elevation. Beck DE et al. (Dis Colon Rectum 2008) — Phase 2 trial showed earlier return of bowel function post-surgery.
Experimental models in the cited papers
- Primary rat pituitary cells
- Conscious swine
What are the limits of this evidence?
The research described concerns the cited experimental materials and models, not proof that this supplied vial is a treatment. Cell or animal findings do not establish human benefits. Clinical findings, where cited, apply to the tested formulation and population; they do not validate this research product for human use.
Study references
- Raun K, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998. PMID 9849822
How should I check lot documentation?
Match the product, strength and lot to an original analysis document. Literature describes experimental findings; it does not verify the contents of this inventory. A report is evidence only for the product, strength and lot it names.
How is Ipamorelin handled in the lab?
For Ipamorelin, record the product code IPAM, selected strength and lot before opening. Follow the material-specific safety data sheet and laboratory SOP, with appropriate gloves, eye protection and containment. For a documented dry preparation, let the sealed vial equilibrate before opening to reduce condensation; minimize time open and use clean, compatible vessels.
Choose a solvent for Ipamorelin from the documented sequence or chemical identity, salt form and assay requirements. Test a small portion first and record pH, solvent composition and clarity. Do not assume one diluent works for every research material; include a solvent-only control and establish compatibility before using the stock in an assay.
For Ipamorelin, calculate mass concentration as measured material mass divided by final solution volume. Calculate molarity only with a documented molecular weight for the supplied chemical form; the catalog lists 711.85 g/mol as a reference, not lot confirmation. Where available, use matched-lot net content rather than treating chromatographic purity as a mass correction. Record both stock concentration and subsequent dilution factors.
Use the documented storage conditions for the supplied Ipamorelin form and lot. For a documented lyophilized preparation, keep the vial sealed and protected from moisture; for solutions, validate temperature, light exposure and holding time in the assay. Use compatible single-use aliquots when appropriate to reduce repeated freeze-thaw. No universal temperature or 28-day solution shelf life is established by the catalog name.
A Ipamorelin laboratory protocol should record identity, product code IPAM, strength, lot, applicable analysis results, solvent and pH, stock concentration, dilution sequence, vessel type, storage history and assay endpoints. Include vehicle and reference controls, independent replicates and predefined acceptance criteria. Separate handling validation from biological interpretation; these notes do not provide administration or dosing instructions.
Research Use Only. Not for human consumption, therapeutic, veterinary or any in-vivo use.
Product Specifications
- Compound
- Ipamorelin
- CAS Number
- 170851-70-4
- Molecular Weight
- 711.85 g/mol
- HPLC Purity Specification
- ≥99%
- Category
- Growth Hormone
- Starting Price
- $39.00 USD
- Country of Origin
- United States
- Shipping
- Cold-chain insulated packaging, fast domestic delivery
- Payment
- Card, ACH, and cryptocurrency (10% discount)
Quality & Verification
Ipamorelin has a catalog purity specification of ≥99%; this is not a measured result for every vial. Match the product, exact strength, batch and lot to its analysis record and read only the reported fields. HPLC peak-area purity, measured content and endotoxin are separate measurements. A blank field means no result is reported, not zero or passed. A purity percentage alone does not establish identity, sterility or suitability for human use.
Frequently Asked Questions
What is Ipamorelin?
Ipamorelin is listed for growth hormone laboratory research. Catalog vial contents are 5mg / 10mg; select the required strength before ordering. This material is supplied for Research Use Only, not as a medicine or a product for human or veterinary use.
What strengths of Ipamorelin are available?
The catalog lists 5mg / 10mg. These labels describe vial contents, not administration doses. Select the required strength for current pricing and availability; match analysis records to that exact strength and lot.
How should I interpret Ipamorelin purity results?
Ipamorelin has a catalog purity specification of ≥99%; this is not a measured result for every vial. Match the product, exact strength, batch and lot to its analysis record and read only the reported fields. HPLC peak-area purity, measured content and endotoxin are separate measurements. A blank field means no result is reported, not zero or passed. A purity percentage alone does not establish identity, sterility or suitability for human use.
How should Ipamorelin be handled in the laboratory?
For Ipamorelin, record the product code IPAM, selected strength and lot before opening. Follow the material-specific safety data sheet and laboratory SOP, with appropriate gloves, eye protection and containment. For a documented dry preparation, let the sealed vial equilibrate before opening to reduce condensation; minimize time open and use clean, compatible vessels.
How do I choose a laboratory solvent for Ipamorelin?
Choose a solvent for Ipamorelin from the documented sequence or chemical identity, salt form and assay requirements. Test a small portion first and record pH, solvent composition and clarity. Do not assume one diluent works for every research material; include a solvent-only control and establish compatibility before using the stock in an assay.
How do I calculate a Ipamorelin stock concentration?
For Ipamorelin, calculate mass concentration as measured material mass divided by final solution volume. Calculate molarity only with a documented molecular weight for the supplied chemical form; the catalog lists 711.85 g/mol as a reference, not lot confirmation. Where available, use matched-lot net content rather than treating chromatographic purity as a mass correction. Record both stock concentration and subsequent dilution factors.
How should Ipamorelin be stored after preparation?
Use the documented storage conditions for the supplied Ipamorelin form and lot. For a documented lyophilized preparation, keep the vial sealed and protected from moisture; for solutions, validate temperature, light exposure and holding time in the assay. Use compatible single-use aliquots when appropriate to reduce repeated freeze-thaw. No universal temperature or 28-day solution shelf life is established by the catalog name.
What should a Ipamorelin lab protocol document?
A Ipamorelin laboratory protocol should record identity, product code IPAM, strength, lot, applicable analysis results, solvent and pH, stock concentration, dilution sequence, vessel type, storage history and assay endpoints. Include vehicle and reference controls, independent replicates and predefined acceptance criteria. Separate handling validation from biological interpretation; these notes do not provide administration or dosing instructions.
Does Fmoc or Boc synthesis explain this Ipamorelin product?
Fmoc and Boc are peptide protecting-group strategies, not proof of how this Ipamorelin lot was made. For sequence-defined peptides, synthesis review can examine deletion products, incomplete deprotection and modifications using the method and matching analytical evidence. A single chromatographic peak does not by itself establish sequence.
Is Ipamorelin for human use?
No. Ipamorelin is strictly Research Use Only. It is not intended for human or veterinary use, diagnosis or treatment. Laboratory handling guidance is not an administration protocol.
Research Use Only. This product is intended for licensed laboratory research and is not for human or veterinary use.
